Comparisons between two biochemical markers in evaluating periodontal disease severity: a cross-sectional study

BMC Oral Health

Suttichai Krisanaprakornkit³  Dhirawat Jotikasthira²  Thanapat Sastraruji³  Peraphan Pothacharoen¹  Siriwan Ongchai¹  Prachya Kongtawelert¹  Sakornrat Khongkhunthian⁴ 

[1] Department of Biochemistry, Thailand Excellence Center for Tissue Engineering and Stem Cells and Center of Excellence for Innovation in Chemistry, Faculty of Medicine, Chiang Mai 50200, Thailand;Department of Orthodontics and Pediatric Dentistry, Faculty of Dentistry, Chiang Mai University, Chiang Mai 50200, Thailand;Department of Oral Biology and Diagnostic Sciences, Center of Excellence in Oral and Maxillofacial Biology, Faculty of Dentistry, Chiang Mai 50200, Thailand;Department of Restorative Dentistry and Periodontology, Faculty of Dentistry, Chiang Mai 50200, Thailand

关键词: Gingival crevicular fluid;    Chronic periodontitis;    Chondroitin sulfate;    Alkaline phosphatase;   

Others  :  1092035
DOI  :  10.1186/1472-6831-14-107

 received in 2014-06-10, accepted in 2014-08-27,  发布年份 2014

【 摘 要 】

Background

The purpose of this study was to compare two biochemical markers, which have been previously used to determine the degrees of alveolar bone destruction, in evaluating periodontal disease severity.

Methods

The WF6 epitope of chondroitin sulfate (CS) and the alkaline phosphatase (ALP) levels were determined in gingival crevicular fluid (GCF) samples collected from patients with various degrees of disease severity, including ten patients with gingivitis (50 gingivitis sites) and 33 patients with chronic periodontitis (including gingivitis, slight, moderate, and severe periodontitis sites; n = 50 each), as well as from ten healthy volunteers (50 healthy sites) by Periopaper strips. The levels of CS and ALP were measured by an ELISA and a fluorometric assay, respectively.

Results

The results demonstrated low levels of CS and ALP in non-destructive and slightly destructive periodontitis sites, whereas significantly high levels of these two biomolecules were shown in moderately and severely destructive sites (p < 0.05). Although a significant difference in CS levels was found between moderate and severe periodontitis sites, no difference in ALP levels was found. Stronger correlations were found between CS levels and periodontal parameters, including probing depth, loss of clinical attachment levels, gingival index and plaque index, than between ALP levels and these parameters.

Conclusions

It is suggested that the CS level is a better diagnostic marker than the ALP level for evaluating distinct severity of chronic periodontitis.

【 授权许可】

   
2014 Khongkhunthian et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Armitage GC: Diagnosis of periodontal diseases. J Periodontol 2003, 74:1237-1247.
• [2]Lamster IB, Ahlo JK: Analysis of gingival crevicular fluid as applied to the diagnosis of oral and systemic diseases. Ann N Y Acad Sci 2007, 1098:216-229.
• [3]Luo L, Xie P, Gong P, Tang XH, Ding Y, Deng LX: Expression of HMGB1 and HMGN2 in gingival tissues, GCF and PICF of periodontitis patients and peri-implantitis. Arch Oral Biol 2011, 56:1106-1111.
• [4]Bakri I, Douglas CW, Rawlinson A: The effects of stress on periodontal treatment: a longitudinal investigation using clinical and biological markers. J Clin Periodontol 2013, 40:955-961.
• [5]Gupta G: Gingival crevicular fluid as a periodontal diagnostic indicator- I: Host derived enzymes and tissue breakdown products. J Med Life 2012, 5(4):390-397.
• [6]Rawlinson A, Grummitt JM, Walsh TF, Ian Douglas CW: Interleukin 1 and receptor antagonist levels in gingival crevicular fluid in heavy smokers versus non-smokers. J Clin Periodontol 2003, 30:42-48.
• [7]Javed F, Al-Hezaimi K, Salameh Z, Almas K, Romanos GE: Proinflammatory cytokines in the crevicular fluid of patients with peri-implantitis. Cytokine 2011, 53:8-12.
• [8]Becerik S, Öztürk VÖ, Atmaca H, Atilla G, Emingil G: Gingival crevicular fluid and plasma acute-phase cytokine levels in different periodontal diseases. J Periodontol 2012, 83:1304-1313.
• [9]Reinhardt RA, Stoner JA, Golub LM, Lee HM, Nummikoski PV, Sorsa T, Payne JB: Association of gingival crevicular fluid biomarkers during periodontal maintenance with subsequent progressive periodontitis. J Periodontol 2010, 81:251-259.
• [10]Lee JH, Choi YJ, Heo SH, Lee JM, Cho JY: Tumor necrosis factor-α converting enzyme (TACE) increases RANKL expression in osteoblasts and serves as a potential biomarker of periodontitis. BMB Rep 2011, 44:473-477.
• [11]Tsuchida S, Satoh M, Kawashima Y, Sogawa K, Kado S, Sawai S, Nishimura M, Ogita M, Takeuchi Y, Kobyashi H, Aoki A, Kodera Y, Matsushita K, Izumi Y, Nomura F: Application of quantitative proteomic analysis using tandem mass tags for discovery and identification of novel biomarkers in periodontal disease. Proteomics 2013, 13:2339-2350.
• [12]Huri CB, Yamalik N, Kilinç K, Kilinç A, Etikan I, Eratalay K: Analysis of the relationship between the severity of periodontal destruction and proteoglycan metabolism of gingiva and gingival crevicular flu. J Clin Periodontol 2003, 30:961-968.
• [13]Bostanci N, Ilgenli T, Emingil G, Afacan B, Han B, Töz H, Atilla G, Hughes FJ, Belibasakis GN: Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio. J Clin Periodontol 2007, 34:370-376.
• [14]Khongkhunthian S, Srimueang N, Krisanaprakornkit S, Pattanaporn K, Ong-Chai S, Kongtawelert P: Raised chondroitin sulphate WF6 epitope levels in gingival crevicular fluid in chronic periodontitis. J Clin Periodontol 2008, 35:871-876.
• [15]Ishikawa I, Cimasoni G: Alkaline phosphatase in human gingival fluid and its relation to periodontitis. Arch Oral Biol 1970, 15:1401-1404.
• [16]Nakashima K, Giannopoulou C, Andersen E, Roehrich N, Brochut P, Dubrez B, Cimasoni G: A longitudinal study of various crevicular fluid components as markers of periodontal disease activity. J Clin Periodontol 1996, 23:832-838.
• [17]Bezerra Júnior AA, Pallos D, Cortelli JR, Saraceni CHC, Queiroz CS: Evaluation of organic and inorganic compounds in the saliva of patients with chronic periodontal disease. Rev Odonto Ciênc 2010, 25:234-238.
• [18]Chapple IL, Glenwright HD, Matthews JB, Thorpe GH, Lumley PJ: Site-specific alkaline phosphatase levels in gingival crevicular fluid in health and gingivitis: cross-sectional studies. J Clin Periodontol 1994, 21:409-414.
• [19]Perinetti G, Paolantonio M, Femminella B, Serra E, Spoto G: Gingival crevicular fluid alkaline phosphatase activity reflects periodontal healing / recurrent inflammation phases in chronic periodontitis patients. J Periodontol 2008, 79:1200-1207.
• [20]Smith AJ, Addy M, Embery G: Gingival crevicular fluid glycosaminoglycan levels in patients with chronic adult periodontitis. J Clin Periodontol 1995, 22:355-361.
• [21]Vardar S, Baylas H, Zihnioğlu F, Emingil G, Buduneli N, Atilla G: Total proteoglycan and chondroitin-4-sulfate levels in gingiva of patients with various types of periodontitis. J Periodontol 2004, 75:393-398.
• [22]Oksala O, Haapasalmi K, Häkkinen L, Uitto VJ, Larjava H: Expression of heparan sulphate and small dermatan/chondroitin sulphate proteoglycans in chronically inflamed human periodontium. J Dent Res 1997, 76:1250-1259.
• [23]Utoh E, Okazaki J, Gonda Y: Analysis of hyaluronic acid in human gingival crevicular fluid using high-performance liquid chromatography. J Osaka Dent Univ 1998, 32:1-7.
• [24]Waddington RJ, Langley MS, Guida L, Iuorio G, Labella R, Embery G, Caruso F: Relationship of sulphated glycosaminoglycans in human gingival crevicular fluid with active periodontal disease. J Periodontal Res 1996, 31:168-170.
• [25]Waddington RJ, Embery G, Smith AJ: Immunochemical detection of the proteoglycans decorin and biglycan in human gingival crevicular fluid from sites of advanced periodontitis. Arch Oral Biol 1998, 43:287-295.
• [26]Intachai I, Krisanaprakornkit S, Kongtawelert P, Ong-chai S, Buranastidporn B, Suzuki EY, Jotikasthira D: Chondroitin sulphate (WF6 epitope) levels in peri-miniscrew implant crevicular fluid during orthodontic loading. Eur J Orthod 2010, 32:60-65.
• [27]Insee K, Pothacharoen P, Kongtawelert P, Ongchai S, Jotikasthira D, Krisanaprakornkit S: Comparisons of the chondroitin sulphate levels in orthodontically moved canines and the clinical outcomes between two different force magnitudes. Eur J Orthod 2014, 36:39-46.
• [28]Nganvongpanit K, Itthiarbha A, Ong-Chai S, Kongtawelert P: Evaluation of serum chondroitin sulfate and hyaluronan: biomarkers for osteoarthritis in canine hip dysplasia. J Vet Sci 2008, 9:317-325.
• [29]Pruksakorn D, Rojanasthien S, Pothacharoen P, Luevitoonvechkij S, Wongtreratanachai P, Ong-Chai S, Kongtawelert P: Chondroitin sulfate epitope (WF6) and hyaluronic acid as serum markers of cartilage degeneration in patients following anterior cruciate ligament injury. J Sci Med Sport 2009, 12:445-448.
• [30]Pothacharoen P, Kalayanamitra K, Deepa SS, Fukui S, Hattori T, Fukushima N, Hardingham T, Kongtawelert P, Sugahara K: Two related but distinct chondroitin sulfate mimetope octasaccharide sequences recognized by monoclonal antibody WF6. J Biol Chem 2007, 282:35232-35246.
• [31]Armitage GC: Periodontal diagnoses and classification of periodontal diseases. Periodontol 2000 2004, 34:9-21.
• [32]Silness J, Löe H: Periodontal disease in pregnancy II: correlation between oral hygiene and periodontal conditions. Acta Odontol Scand 1964, 22:121-135.
• [33]Löe H, Silness J: Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963, 21:533-551.
• [34]Makeudom A, Kulpawaropas S, Montreekachon P, Khongkhunthian S, Sastraruji T, Pothacharoen P, Kongtawelert P, Krisanaprakornkit S: Positive correlations between hCAP18/LL-37 and chondroitin sulphate levels in chronic periodontitis. J Clin Periodontol 2014, 41:252-261.
• [35]Sanikop S, Patil S, Agrawal P: Gingival crevicular fluid alkaline phosphatase as a potential diagnostic marker of periodontal disease. J Indian Soc Periodontol 2012, 16:513-518.
• [36]Taba M Jr, Kinney J, Kim AS, Giannobile WV: Diagnostic Biomarkers for Oral and Periodontal Diseases. Dent Clin N Am 2005, 49:551-571.
• [37]Todorovic T, Dozic I, Vicente-Barrero M, Ljuskovic B, Pejovic J, Marjanovic M, Knezevic M: Salivary enzymes and periodontal disease. Med Oral Patol Oral Cir Bucal 2006, 11:E115-E119.
• [38]Nakashima K, Roehrich N, Cimasoni G: Osteocalcin, prostaglandin E2 and alkaline phosphatase in gingival crevicular fluid: their relations to periodontal status. J Clin Periodontol 1994, 21:327-333.
• [39]Cho M-I, Garant PR: Development and general structure of the periodontium. Periodontol 2000 2000, 24:9-27.
• [40]Loos BG, Tjoa S: Host-derived diagnostic markers for periodontitis: do they exist in gingival crevice fluid? Periodontol 2005, 39:53-72.
• [41]Whyte MP, Landt M, Ryan LM, Mulivor RA, Henthorn PS, Fedde KN, Mahuren JD, Coburn SP: Alkaline phosphatase: placental and tissue-nonspecific isoenzyms hydrolyze phosphoethanolamine, inorganic pyrophosphate, and pyridoxal 5’-phosphate. Substrate accumulation in carriers of hypophosphatasia corrects during pregnancy. J Clin Invest 1995, 95:1440-1445.
• [42]Yoshinari K, Matsumoto K, Misaki H: Differential patterns of expression of glycosylphosphatidylinositol-anchored carcinoembryonic antigen and alkaline phosphatase in various cancer cell lines. Cytotechnology 1999, 31:255-263.
• [43]Ferianec V, Linhartová L: Extreme elevation of placental alkaline phsphatase as a marker of preterm delivery, placental insufficiency and low birth weight. Neuro Endocrinol Lett 2011, 32:154-157.
• [44]Daltaban O, Saygun I, Bal B, Baloş K, Serdar M: Gingival crevicular fluid alkaline phosphatase levels in postmenopausal women: Effects of phase I periodontal treatment. J Periodontol 2006, 77:67-72.
• [45]Sorsa T, Tjäderhane L, Konttinen YT, Lauhio A, Salo T, Lee HM, Golub LM, Brown DL, Mäntylä P: Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 2006, 38:306-321.